Michael Adler
- Hepatology top 0.5%
- Liver Disease and Transplantation 24
- Hepatitis C virus research 21
- Liver Diseases and Immunity 7
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 39
- Hepatitis B Virus Studies 16
- Gastroenterology top 5%
- Surgery top 5%
- Organ Transplantation Techniques and Outcomes 6
-
- Inflammatory Bowel Disease 4
- Co-authors
- Fenton SchaffnerMichel CremerA. Van GossumNadine BourgeoisFrance GayKenneth E. ShermanMichael FriedNezam H. Afdhal
- Journals
- Journal of Hepatology (9 papers)Transplant International (4 papers)Digestive Diseases and Sciences (4 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Michael Adler
78 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Hepatology 1.7k
- Epidemiology 1.8k
- Gastroenterology 164
- Endocrinology, Diabetes and Metabolism 385
- Surgery 716
Countries citing papers authored by Michael Adler
This map shows the geographic impact of Michael Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Adler more than expected).
Fields of papers citing papers by Michael Adler
This network shows the impact of papers produced by Michael Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Adler. The network helps show where Michael Adler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Adler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | Response of Black African patients with hepatitis C virus genotype 4 to treatment with peg-interferon and ribavirin. | 2013 | 1 |
| 3 | 2011 | 7 | |
| 4 | Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study. | 2010 | 3 |
| 5 | 2010 | 43 | |
| 6 | 2008 | 32 | |
| 7 | 2008 | 37 | |
| 8 | 2004 | 32 | |
| 9 | Controversies in gastroenterology | 2000 | 1 |
| 10 | 1999 | 31 | |
| 11 | 1998 | 302 | |
| 12 | 1997 | 38 | |
| 13 | 1995 | 47 | |
| 14 | 1995 | 23 | |
| 15 | 1992 | 36 | |
| 16 | 1992 | 3 | |
| 17 | 1992 | 3 | |
| 18 | 1992 | 43 | |
| 19 | 1990 | 41 | |
| 20 | 1990 | 25 |
About Michael Adler
Michael Adler is a scholar working on Hepatology, Epidemiology and Complementary and Manual Therapy, having authored 81 papers that have together received 3.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (24 papers), Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (16 papers), Liver Diseases and Immunity (7 papers), Organ Transplantation Techniques and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Hepatology (1.7k citations), Epidemiology (1.8k citations) and Gastroenterology (164 citations). Michael Adler has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Fenton Schaffner, Michel Cremer, A. Van Gossum, Nadine Bourgeois, France Gay, Kenneth E. Sherman, Michael Fried, Nezam H. Afdhal, Nathalie Adda and Abdul J. Sankoh. Their work appears in journals such as Journal of Hepatology, Transplant International, Digestive Diseases and Sciences, Gastrointestinal Endoscopy and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.